Art

J-GLOBAL ID：201702243576350442   Reference number：17A0389849

Musculoskeletal Tumor 骨・軟部腫瘍 III.がん免疫療法の進歩と骨軟部腫瘍における現状

Author (1)： KITANO SHIGEHISA (国立がん研究セ 中央病院 先端医療科)
Material： 癌と化学療法  (Japanese Journal of Cancer and Chemotherapy)
Volume： 44  Issue： 3  Page： 222-226  Publication year： Mar. 15, 2017 
JST Material Number： Z0938A  ISSN： 0385-0684  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *bone tumor ,...
Semi thesaurus term： *bone and soft tissue tumor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0389849&from=J-GLOBAL&jstjournalNo=Z0938A") }}

JST classification (2)： Tumors(=neoplasms)of musculoskeletal system  (GG04000A) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (22)：

• Brunet JF, Denizot F, Luciani MF, et al: A new member of the immunoglobulin superfamily-CTLA-4. Nature 328 (6127): 267-270, 1987.
• Krummel MF and Allison JP: CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182 (2) : 459-465, 1995.
• Leach DR, Krummel MF and Allison JP: Enhancement of antitumor immunity by CTLA-4 blockade. Science 271 (5256): 1734-1736, 1996.
• Ishida Y, Agata Y, Shibahara K, et al: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11 (11): 3887-3895, 1992.
• Freeman GJ, Long AJ, Iwai Y, et al: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192 (7) :1027-1034, 2000.

Terms in the title (4)： 骨・軟部腫瘍 ,  がん免疫療法 ,  骨軟部腫瘍 ,  現状